First cannabis-based product under MCAP to be available from next month

The first cannabis-based product to be made available through the Medical Cannabis Access Programme will be accessible from mid-October.

The product is CannEpil oral solution which contains both tetrahydrocannabinol (THC) a psychoactive derivative of cannabis, and cannabidiol (CBD).

Professor Bryan Lynch, Consultant Paediatric Neurologist in Temple Street Children’s Hospital, told the Oireachtas Health Committee that the levels of THC in the product are too high to treat patients with severe epilepsy as THC is not clinically indicated for the condition.

Read more…

Source: The Irish Examiner; Accessed online on September 30th 2021